LONDON (ShareCast) - (Sharecast News) - Carr's Group announced a strategic manufacturing partnership with French animal health company Vétalis on Friday, to develop an enhanced range of Tracesure boluses, with distribution due to begin in autumn 2025.
The London-listed firm said the move followed its decision to close its ANIMAX production facility in June, allowing it to shift resources towards innovation and growth in livestock nutrition.

It said the partnership was expected to deliver operational savings while maintaining Tracesure's leading position in the UK and Irish markets.

Vétalis, a specialist in precision bolus supplementation, would support Carr's in developing new science-backed formulations aimed at improving animal health and supporting sustainable farming practices.

Carr's said the collaboration would support its strategy of boosting on-farm productivity and addressing global food security challenges.

The combination of Vétalis' manufacturing expertise and Carr's nutrition capabilities was intended to drive innovation, improve efficiency, and enhance product delivery.

"This is a key strategic milestone as we reposition the Group as a focused, pure-play agriculture business," said chief executive officer Joshua Hoopes

"Partnering with Vétalis enables us to build a more efficient platform for sustainable growth, while strengthening our customer offering and creating long-term value for shareholders."

At 1307 BST, shares in Citywire were up 5.53% at 146.18p.

Reporting by Josh White for Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE